RE: Similarities Between CVS & MPAL11 May 2026 08:47
That you buying bunsen? So much potential this thing.
π
Management says pharmacy-level EBITDA breakeven is forecast at 80,000 items per month.
In March, MedPal was already over 40,000 items.
Now it has added a second facility with historic capacity above 100,000 items per month.
With 34%+ gross margins and automated dispensing infrastructure, higher volumes could create strong operating leverage.
The opportunity is simple: if MedPal can reactivate the Runcorn patient and care home book while continuing to grow MedPal.clinic, the revenue base could change quickly.